Data from Phase 2b IMPACT Trial of Pemvidutide in MASH Expected Before Year End End-of-Phase 2 Meeting with FDA for MASH Program Scheduled in Fourth Quarter Executive Leadership Strengthened with ...
A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback